Reports Q3 revenue $96.06M, consensus $95.64M. “A strong balance sheet and disciplined cost-management underpin our focused business execution,” said Emily Leproust, CEO and co-founder of Twist Bioscience (TWST).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWST: